| Old Articles: <Older 23081-23090 Newer> |
|---|
 |
The Motley Fool
May 9, 2007
Mike Havrilla |
A Hard Sell at North Pitt With a stagnant stock price for most of the last two years and fierce competition from much larger companies, don't be shocked if frustrated shareholders drive this telecom's management toward a sale.   |
The Motley Fool
May 9, 2007
Rich Smith |
Gateway Swings the Other Way Gateway might do well for itself, and its shareholders, if it makes use of its smaller size to dance nimbly among the giants. To poach the very best, and most profitable, corporate accounts while its larger rivals are occupied elsewhere. |
The Motley Fool
May 9, 2007
Rick Aristotle Munarriz |
Name Your Own Priceline The online travel site flies up and down in its latest quarter. Investors, take note. |
The Motley Fool
May 9, 2007
Rick Aristotle Munarriz |
Disney Hits Another Home Run Investors, one of these days, Disney CEO Bob Iger will miss. Just not today. The family-entertainment giant makes the most of what it's got for the quarter. |
The Motley Fool
May 8, 2007
Anders Bylund |
3 Stocks That Missed the Mark A peek at companies that over-promised and under-delivered. Jones Soda... JDS Uniphase... OfficeMax... |
The Motley Fool
May 8, 2007
Jeremy MacNealy |
Fool on Call: Profit From Oil by Investing in Ovens? From the oil boon to the Baby Boom, there are many reasons to invest in this oven maker. |
The Motley Fool
May 8, 2007
Toby Shute |
Who's Making Windfall Profits? Let's play Pick the Profiteer! Your choice of these four companies will indicate the industry that's clearly making more than its fair share. And it's not Big Oil. |
The Motley Fool
May 8, 2007
Alyce Lomax |
April's Cruel to Urban Outfitters One tough month drags down the retailer's first-quarter comps. Investors, take note. |
The Motley Fool
May 8, 2007 |
Guitar Center Shreds Expectations: Fool by Numbers The musical instrument retailer released first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
May 8, 2007
Brian Lawler |
Neurocrine Is Waking Up After being put to sleep for much of 2006 following an unexpected FDA smackdown on its lead drug, indiplon, shares of the biopharma have boosted over 50% higher versus its lows last year. |
| <Older 23081-23090 Newer> Return to current articles. |
